跳至主要内容
临床试验/NCT05168059
NCT05168059已完成不适用

Clevidipine for Acute High Blood Pressure Control in Neurocritical Patients

Hospital de Cruces1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2017年1月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
33
试验地点
1
主要终点
Effectiveness of clevidipine

研究概览

简要总结

Acute blood pressure elevation is a frequent problem in neurocritical patients. Its effective management is challenging and must avoid significant decreases of blood pressure leading to lower cerebral perfusion pressure worsening ischemia and elevations probably associated with bleeding, rebleeding or hematoma expansion associated with poor prognosis

详细描述

Retrospective, observational and single-group study for observe effectiveness and safety of clevidipine for perioperative control of hypertension in patients admitted to Post-Operative Intensive Care Unit after thrombectomy for stroke, intracerebral hemorrhage requiring surgical treatment, embolization of aneurysm after subarachnoid hemorrhage, scheduled neurosurgical and neuroradiology procedures.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Effectiveness of clevidipine

时间窗: 1 to 6 hour of clevidipine infusion beginning

Percentage of patients achieving target systolic blood pressure (SBP)

次要结局

  • Incidence of adverse events related to clevidipine treatment(1 hour after beginning to 24 hours after clevidipine infusion stop)

研究者

发起方
Hospital de Cruces
申办方类型
Other
责任方
Principal Investigator
主要研究者

Blanca Escontrela

Consultant Anesthesiology and Reanimation

Hospital de Cruces

研究点 (1)

Loading locations...

相似试验